معرفی
Amanda L Kong is a Professor of Surgery and Section Chief of Breast Surgery in the Division of Surgical Oncology at the Medical College of Wisconsin. She is a board-certified surgical oncologist specializing in breast cancer and benign breast diseases with leadership roles including Vice Chair of the Breast Fellowship Training Committee of the Society of Surgical Oncology and State Chair for Wisconsin for the Commission on Cancer.
Dr. Kong's educational background includes:
- Doctor of Medicine from Warren Alpert Medical School of Brown University (2002)
- General Surgery Residency at Mount Sinai Hospital, New York City (2003-2007)
- Breast Surgical Oncology Fellowship at The University of Texas MD Anderson Cancer Center (2007-2008)
- Master of Science in Epidemiology from the Medical College of Wisconsin (2010)
Her research centers on breast cancer disparities across racial, ethnic, and age groups, hospital volume effects on treatment quality, and quality-of-life optimization for survivors. Using large administrative databases and tumor registries, she investigates care variations in high- versus low-volume centers and develops evidence-based approaches for elderly patients balancing treatment efficacy with well-being.
Analysis of her 2024-2025 publications reveals consistent focus on surgical decision-making, disparities research, and health services outcomes. Key themes include sentinel lymph node biopsy utilization patterns, neoadjuvant therapy trends for HER2-positive cancer, and online information quality—highlighting her commitment to data-driven improvements in breast cancer care delivery and equity.
Dr. Kong's honors include:
- Fellow of the American College of Surgeons
- Fellow of the Society of Surgical Oncology
- Best Doctor by M Magazine
- Best Doctors in America designation
- Multiple Medical College of Wisconsin Outstanding Medical Student Teaching Awards
- Excellence in Professionalism Award (2016)
A dedicated mentor to students and residents, she integrates clinical practice with research through the CAPS group (formerly PCOR) to address real-world patient care challenges. Her leadership in national committees shapes surgical oncology training standards and Commission on Cancer accreditation while advancing evidence-based practice guidelines.
As surgical lead for the Froedtert & MCW Inflammatory Breast Cancer Program (IBC Connect consortium), she directs a multidisciplinary team focused on rare breast cancer subtypes. Her research group leverages tumor registries and administrative databases to identify disparities and optimize care pathways across diverse patient populations.
